Rob Stewart

Amneal among companies to launch generic version of Lyrica

Amneal among companies to launch generic version of Lyrica

BRIDGEWATER, N.J.  — The Food and Drug Administration has approved a number of applications for the generic version of Pfizer’s Lyrica (pregabalin). The  FDA gave the green light to the following companies: Amneal, Alembic, Alkem, Dr. Reddy’s, InvaGen, MSN Laboratories, Rising Pharmaceuticals, Sciegen, and Teva. Amneal’s  generic version of Lyrica (pregabalin capsules) will be available

Amneal announces restructuring and costs savings plan

Amneal announces restructuring and costs savings plan

BRIDGEWATER, N.J. — Amneal Pharmaceuticals announced this week  a comprehensive restructuring plan designed to reduce its cost base, further right size its organization and optimize its global manufacturing infrastructure. “Recently we initiated an in depth, company-wide review of our organizational structures, operational budgets, current and future capital projects, and existing capability and infrastructure alignments,” said